Xia Lizi, Burger Wessel A C, van Veldhoven Jacobus P D, Kuiper Boaz J, van Duijl Tirsa T, Lenselink Eelke B, Paasman Ellen, Heitman Laura H, IJzerman Adriaan P
Division of Medicinal Chemistry, Leiden Academic Centre for Drug Research, Leiden University , 2300 RA Leiden, The Netherlands.
J Med Chem. 2017 Sep 14;60(17):7555-7568. doi: 10.1021/acs.jmedchem.7b00950. Epub 2017 Aug 30.
We expanded on a series of pyrido[2,1-f]purine-2,4-dione derivatives as human adenosine A receptor (hAR) antagonists to determine their kinetic profiles and affinities. Many compounds showed high affinities and a diverse range of kinetic profiles. We found hAR antagonists with very short residence time (RT) at the receptor (2.2 min for 5) and much longer RTs (e.g., 376 min for 27 or 391 min for 31). Two representative antagonists (5 and 27) were tested in [S]GTPγS binding assays, and their RTs appeared correlated to their (in)surmountable antagonism. From a k-k-K kinetic map, we divided the antagonists into three subgroups, providing a possible direction for the further development of hAR antagonists. Additionally, we performed a computational modeling study that sheds light on the crucial receptor interactions, dictating the compounds' binding kinetics. Knowledge of target binding kinetics appears useful for developing and triaging new hAR antagonists in the early phase of drug discovery.
我们拓展了一系列吡啶并[2,1-f]嘌呤-2,4-二酮衍生物作为人腺苷A受体(hAR)拮抗剂,以确定它们的动力学特征和亲和力。许多化合物表现出高亲和力和多样的动力学特征。我们发现了在受体处具有非常短停留时间(RT)的hAR拮抗剂(化合物5的RT为2.2分钟)以及长得多的RT(例如,化合物27的RT为376分钟或化合物31的RT为391分钟)。在[S]GTPγS结合试验中测试了两种代表性拮抗剂(化合物5和27),它们的RT似乎与其可(不)克服的拮抗作用相关。从k-k-K动力学图中,我们将拮抗剂分为三个亚组,为hAR拮抗剂的进一步开发提供了一个可能的方向。此外,我们进行了一项计算建模研究,该研究揭示了关键的受体相互作用,决定了化合物的结合动力学。在药物发现的早期阶段,了解靶点结合动力学对于开发和筛选新的hAR拮抗剂似乎是有用的。